Bovine Blood Plasma Derivatives Market Report 2025 (Global Edition)

Global Bovine Blood Plasma Derivatives Market Report 2025 Market Size Split by Type (Bovine Serum, FBS, Bovine Serum Albumin, Fibrinogen, Protein Ingredient, Other), by End-user (Scientific Research, ...

Bovine Blood Plasma Derivatives Market Report Description

We have various report editions of Bovine Blood Plasma Derivatives Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Key players deploy strategic initiatives such as product innovations, partnerships, and mergers. Companies prioritize R&D and contribute to the growth of the Global Bovine Blood Plasma Derivatives Market. The Bovine Blood Plasma Derivatives Market has started to become increasingly competitive with a lot of big firms expanding the use of Bovine Blood Plasma Derivatives for several applications in industries. Therefore, there is a huge demand driving the market which should enable the key players in the market to provide efficient solutions. 

Top Companies Market Share in Bovine Blood Plasma Derivatives Industry: (In no particular order of Rank)

• Thermo Fisher
• GE Healthcare
• Merck (Sigma-Aldrich)
• Moregate BioTech
• Gemini
• Atlanta Biologicals
• Tissue Culture Biologicals
• Bovogen
• Biowest
• Internegocios
• RMBIO
• Biological Industries
• VWR
• Corning
• Serana
• Lanzhou Minhai
• Zhejiang Tianhang Biotechnology
• ExCell Bio
• Jin Yuan Kang
• American Protein Company
• Sonac
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Based on region, North America dominates the market and will continue to show strong growth throughout the forecast period with XX% CAGR. Growth in the healthcare sector has long been a top priority in the area and throughout North America. In addition, the province is witnessing simultaneous expansion and advancement in the market for derivatives made from bovine blood plasma. The main reason for this country's growth in the international market has been the existence of pioneers who are making constant efforts via pertinent research and exploration in the area. In addition to investing significant resources in R&D, major industry participants are fostering partnerships by launching mergers and acquisitions with other businesses, primarily to expand their geographical footprint. High demand for pharmaceuticals and biotechnology products is driving the market dynamics in North America. Research and development activities related to medical products and biotechnology are also boosting the demand for bovine blood plasma derivatives in the region. For instance, on March 22, 2021, Thermo Fisher Scientific, a U.S.-based company that manufactures pharmaceutical and diagnostic products launched the new Gibco Human Plasma-like Medium (HPLM), which is the first cell culture medium in the market that mimics the metabolic profile of human plasma. Gibco HPLM has the same levels of over 60 polar metabolites including amino acids, nucleic acids, sugars, and tiny organic acids, as those found in human plasma.

The current report Scope analyzes Bovine Blood Plasma Derivatives Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

Bovine Blood Plasma Derivatives Market Analysis

Based on type segment, market is bifurcated into Bovine Serum, FBS, Immunoglobulins, Bovine Serum Albumin, Fibrinogen, Protein Ingredient, Others. Immunoglobulins hold the largest market share and will continue to dominate the market in the upcoming years. Numerous gastrointestinal disorders can be treated and managed using immunoglobulins. Multiple research studies have shown that serum-derived bovine immunoglobulin/protein isolate is useful in lowering diarrhea and regaining the digestive tract's capacity to absorb and utilize nutrition correctly. Human passive immunization is another usage for bovine immunoglobulins. Such immunoglobulins can also be added to vaccinations intended to combat certain infections, offering a focused method of preventing illness. A growing number of different medical diagnostic R&D projects are using derivatives of bovine blood plasma. Due to its extensive usage in several operations and diagnostic procedures, thrombin is becoming more and more well-liked in the medical community. It is frequently used alongside absorbing agents and fibrinogen in fibrin glues, among other hemostatic agents. Studies on coagulation, in vitro studies, medicine, biochemistry, and protein structure analysis are just a few of the many fields in which derivatives of cow blood plasma are used extensively. Therefore, the bovine blood plasma derivatives market is driven by research and development of diagnostic tests. The blood plasma market is anticipated to be driven by the increase in the frequency of life-threatening conditions including immunodeficiency, the aging population, and the growing uptake of goods made from blood plasma derivatives. The study on the global blood plasma market offers a comprehensive analysis of the industry for the duration of the projection. The study is divided into different sections and includes an analysis of the trends and aspects that are important to the industry. For instance, in 2020, Grifols, S.A. (Spain) gathered blood plasma derivatives for the delivery of hyper-immune globulin with an increased number of antibodies from recuperated COVID-19 patients for the potential treatment of COVID-19 illness.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Bovine Blood Plasma Derivatives Industry. Request a Free Sample PDF!

Based on end user, the market is bifurcated into Healthcare Sector, Scientific Research, Industrial Production, Feed and Others. The healthcare sector is expected to dominate during the forecast period, owing to an increase in prevalence of the chronic and infectious such as immunodeficiency disorders, hemophilia, and initiatives taken by government and private organizations to develop the advanced healthcare sector. Platelet-rich plasma and its byproducts have been studied extensively and used in reformative medicine over the past several years. It has consistently been shown that adding this ingredient to cell culture medium increases stem cell motility, proliferation, and differentiation. Meanwhile, evidence that platelet-rich plasma (PRP) contains large amounts of growth and cluster proteins, which in turn explain the reformative process, supports the use of PRP in science and medicine. PRP-based therapies and cures are reasonably priced and advantageous in terms of accessibility and security of utilizing the patient's unique growth factors. PRP-based biomaterials have advanced significantly over the past ten years for both tectonic and ascetic applications. 
Medical research, in vitro studies, coagulation studies, protein structure analysis, and biochemical studies are among the R&D uses of Bovine Blood Plasma Derivatives.  Until 2027, it is anticipated that the market for derivatives made from bovine blood plasma will continue to be led by the second-ranking sector, which is low serum albumin. Applications for bovine serum albumin include the food and pharmaceutical industries, as well as cell culture mediums. The manufacturing of different vaccines and tasks connected to cell cultures, such as cryopreservation and efficient cell washing, both need the use of albumins obtained from cows. For instance, in 2021, The Hospital del Mar Medical Research Institute (IMIM), Hospital del Mar, the University of California-Davis, and the University of Texas launched a clinical trial to analyze how useful a food supplement can be for preventing the worst side effects of COVID-19. The study is looking at bovine-derived immunoglobulins, which have been shown in animal models to reduce the inflammation caused by infection, progression to more severe forms of the disease, and post-COVID syndrome.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Author's Detail

Manoj Phagare

Senior Research Analyst at Cognitive Market Research

LinkedIn

Profile

• Worked on several market, industry & business research projects, on various models such as Syndicated, Custom, Subscriptions and Consults
• Proficient in secondary research and familiar with all paid research databases
• Proficient in primary research and handling client queries through mails and calls
• Expertise in statistical techniques used in data forecasting, possess strong grip on all aspects of market engineering & data analysis
• Expertise in checking feasibility of projects based on Request for Proposal (RFPs) of clients
• Acquainted with entire process of report writing- Title Analysis, TOC Building, Search Engine Optimization, TOC Freezing, Writing Reports, Market Engineering, Scheduling Primaries, Directory of Key Industry Participants (DKIP), Drafting “Press Articles/Summary/Report Description/Analyst Briefing” used for making marketing collaterals 
• Gained team-work skills in coordinating with the sales teams for business development and meeting needs of a variety of clients hand-in-hand with promoting sales.

Author's Conclusion